Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.38NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.251NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.2.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.256NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.26NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.77NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.34NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.248NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.32NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.425NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.144NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.288NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.249NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.378NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.97NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.439NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.408NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.256NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.237NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBNNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBJ.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.356NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.462NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.29NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.147NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
P.1.6 (Gamma)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
P.1.5 (Gamma)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
P.1.4 (Gamma)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.420NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.168NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.36.39NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.57NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AH.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.289NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.365NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.252NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.223NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.640.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.127.1 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.88NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AP.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-1212.29Singapore
AK.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.98.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.1.13.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.34.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.124.1.1 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.203NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used